Results 221 to 230 of about 17,488 (290)

Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development

open access: yesSmall, EarlyView.
Extracellular vesicles (EVs) hold promise for chronic obstructive pulmonary disease (COPD) treatment but face challenges with storage and delivery. This study demonstrates the stabilization of lung fibroblast‐derived EVs using inulin, enabling freeze‐drying and spray‐drying.
Eva M. Jansen   +7 more
wiley   +1 more source

Development of a Physiologically Based Pharmacokinetic (PBPK) Simulation Model for Nicotine. [PDF]

open access: yesBiopharm Drug Dispos
Kim B   +8 more
europepmc   +1 more source

Biopharmaceutic

open access: yesJournal of Pharmacy and Pharmacology, 2006
openaire   +1 more source

Thermosensitive Nanostructured Coacervates Developed by Mixing ABA‐ and AB‐Block Copolymers and Their Unique Sustained Release of Nano‐Micelles in a Regulated Manner

open access: yesSmall, EarlyView.
Polyion complex micelles composed of blends of ABA and AB block copolymers can form coacervates with a hexagonally packed cylinder nanostructure after heating. The resulting coacervates can release the micelles under physiological conditions in a zero‐order kinetics, possessing cargo proteins.
Takumi Egashira   +9 more
wiley   +1 more source

Polyamide Acid–Based Surface Modification of Poly(p‐Phenylene Benzobisoxazole) Fibres Reinforcing Syntactic Foam for Using Them as High‐Performance Insulating Core Material

open access: yesHigh Voltage, EarlyView.
ABSTRACT The insulating core is an important part of pillar composite insulators used in power transmission systems. Traditional insulating core materials suffer from various problems that can threaten the reliability of insulated equipment. Syntactic foam (SF) exhibits excellent properties, such as a low density, water penetration resistance and high ...
Le Li   +8 more
wiley   +1 more source

Physiologically-Based Biopharmaceutics Modeling for Ibuprofen: Identifying Key Formulation Parameter and Virtual Bioequivalence Assessment. [PDF]

open access: yesPharmaceutics
Zarzoso-Foj J   +5 more
europepmc   +1 more source

Separation of R&D Processes in a Biopharmaceutical R&D

open access: bronze, 2017
Toshikazu MIYASHIGE   +25 more
openalex   +1 more source

Proteomic and Transcriptomic Signatures of Poor Asthma Symptom Control in the U‐BIOPRED Cohort

open access: yesAllergy, EarlyView.
No stable features were identified as associated with asthma symptom control in transcriptomics or sputum proteomics. Higher TWEAKR/TNFRSF12A and MBL/MBP‐C serum levels increased the odds of uncontrolled symptoms, while higher MK08/MAPK8 and CD5L serum levels decreased the odds, after adjustment for clinical variables.
Joana Antão   +294 more
wiley   +1 more source

Home - About - Disclaimer - Privacy